10.19.26 -- Next-Generation Molecules Challenge Notions Of Yield And Performance

Modern sequencing methods offer sensitive detection of adventitious and species‑specific viruses. Learn how targeted and non‑targeted NGS approaches improve confidence in cell bank characterization.

Explore a scalable, sterile solution for isolating extracellular vesicles (EVs) in exosome therapeutics to enhance yield, purity, and commercial viability through innovative filtration technology.

A chemically defined fed-batch bioprocess medium simplifies hMSC-EV production, increasing yields while maintaining EV quality across donors and tissue types in scalable GMP-compatible environments.

Sequential genetic integration can equip stable cell lines with multiple functions. Uncover applications spanning antibody production, glycosylation control, receptor knockdown, and lentiviral packaging.

Advancements in high-sensitivity residual DNA testing enhance the precision of plasmid DNA purity analysis, ensuring compliance with regulatory standards critical for manufacturing processes.

Middlesex County, NJ, is a hotbed for the life sciences, offering a deep talent pool, an extensive R&D presence, and dedicated backing by local government in the form of strategic investment.

Discover how diagnosing ribosome pausing sites and optimizing codon usage dramatically improves bispecific antibody titers, turning difficult-to-express candidates into viable therapeutics.

Demonstrating residual reagent clearance is a critical regulatory requirement in AAV manufacturing. Examine how specialized assays and strategic partnerships streamline compliance.

A common requirement for media and buffer preparation in biopharma processing is powder-liquid mixing. Review the performance of a 3000 L single-use mixing system for preparing aqueous solutions.

Low AAV productivity and lack of platform processes continue to drive AAV production costs up. Take a look at a robust and scalable suspension manufacturing platform for AAV production.